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INTRODUCTION 
Lung cancer is presently one of the most common malignancies 
through out the world. There has been an increase in incidence in the last 
50 years. All histological types of lung cancer increasing incidence but 
different degrees. During a period of  refinement of thoracic departmental 
lung cancer tumour registry it became apparent that along with an 
increasing incidence of lung cancer among women there was also an 
increasing prevalence of adenocarcinoma among lung cancer patients of 
both sex. 
Primary studies in India show an increasing trend in lung cancer 
compared to a quarter of century ago. Studies from India have 
emphasized significant epidemiological and cell type difference that exist 
in the country compared to that reported in the west. The increase in 
incidence of  bronchogenic carcinoma is not only due to better diagnostic 
facilities like flexible fibreoptic bronchoscopy but also other factors like 
increase in number of smokers, increasing environmental pollution and 
increase in number of people living in higher age groups. 
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AIM OF STUDY 
An open prospective study was undertaken to 
study  the recent profile of Lung cancer. 
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REVIEW OF LITERATURE 
A. EPIDEMIOLOGY 
Age  
Bronchogenic carcinoma is mainly a disease of middle age.  
However it may develop in very old and in children. It has been recorded 
in a child as young as 10 years. The peak frequency of bronchogenic 
carcinoma is between 50 to 60 years in India and the  incidence below 40 
years is less frequent. The average age of brochogenic carcinoma was 
51.7 years in a study conducted by Jindal.  
Sex  
Bronchogenic carcinoma is predominantly a disease of men. But 
the incidence is steadily increasing in females in most industrialized 
countries. The male female ratio was 4.1:1 in conducted by Jindal and 
Behera in 1990. 
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Smoking 
The suspicion that smoking could cause cancer was first noticed in 
1761 when John Hill reported the occurrence of polyps in snuff takers. 
Ochsner in 1971, first recognised the relation between smoking and 
increasing incidence of lung cancer. 
In a study conducted by Jindal and Behera in India, the overall 
smoker: non smoker ratio was 2.68:1. The study was conducted over 
1009 patients over 10 years. Different studies overall the world have 
established the following observations.  
1. Cigarette smokers are ten times likely to develop lung cancer in 
comparison to life long non smokers. The extent of risk correlates 
with the number and duration of cigarette smoked and risk of lung 
cancer decreases as the period of abstinence increases. 
a. Filter cigarette are less harmful. Beedi smoking which is a 
common practice in India is equally if not more harmful than 
cigarette. 
2. The principal carcinogenic agent is the inhaled combustion product 
of the particular matter (tar). Particular attention has been paid to 
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aryl hydrocarbon hydroxylase (AHH) which converts polycyclic 
hydrocarbons found in cigarette smoke to metabolites that are 
potent cacinogens. 
3. Passive smoking (air pollution from another person’s tobacco 
smoke) plays a prime role in causation of lung cancer (Svendsen  
et al.,) 
4. Risks of cigarette smokers are much lower in our country as 
compared to the western countries. 
Occupational factors 
Information about occupational carcinogenesis is adequate due to 
lack of large number of epidemiological study and the long lag period 
between the exposure and clinical manifestation. Smith et al., found 
average benzo(a)pyrene exposure during cooking period from 4 villages 
in western India to be nearly 4000 ng/m3 and it is equivalent to smoking 
20 cigarette per day. Asbestos fiber increases the incidence of lung cancer 
and cigarette smoking greatly increases (90 fold) the incidence of lung 
cancer in asbestos workers. Inhalation of decay products of radon is the 
predominant carcinogenic influence i.e. more than that of radon itself. 
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Other agents line arsenic, nickel, chromium, chloroethylether, mustard 
gas are associated with increased incidence of lung cancer. 
B. HISTOLOGICAL CLASSIFICATION OF LUNG CANCER 
Considering the heterogeneity of lung cancer, WHO has provided an 
appropriate basic nomenclature of lung cancer based on light microscopy 
(1981) 
1) Squamous cell carcinoma 
Variants: spindle cell (squamous)carcinoma.   
2) small cell carcinoma 
a)      Oat cell carcinoma 
b)       Intermediate cell type  
c)       Combined oat cell carcinoma  
  Adenocarcinoma 
d)      Acinar 
e)      Papillary 
f)      Broncho-alveolar carcinoma 
g)      Solid carcinoma with mucous production 
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3) large cell carcinoma 
a)     Gaint cell carcinoma 
b)      Clear cell carcinoma 
4) Adenosquamous carcinoma 
5) Carcinoid tumors 
6) Bronchial gland carcinoma 
a) Adenoid cyst carcinoma 
b) Muco- epidermoid carcinoma 
c) others. 
   
7) Others 
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Recent classification of Invasive Malignant Tumor by 
WHO 
1999, 3rd Berlin, Germany: Springer-Verlag. 
1.  squamous cell carcinoma 
        Variants 
               Papillary 
               Clear cell  
               Small cell  
               Basaloid 
2. small cell carcinoma 
      Variants 
              Combined small cell carcinoma 
3. Adenocarcinoma 
      Acinar 
      Papillary 
      Bronchiolalveolar carcinoma 
                  Non Mucinous (Clara cell/type2 Pneumocyte) 
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                  Mucinous (goblet cell type) 
                 Mixed mucinous and non mucinous 
                 (Clara cell/type 11 pneumocyte and goblet cell type) or 
indeterminate. 
                 Solid Adenocarcinoma with mucin formation 
                 Mixed 
Variants 
Well differentiated fetal Adenocarcinoma 
       Mucinous (colloid) 
       Mucinous cystadenocarcinoma 
Signet ring 
       Clear cell 
4. Large cell carcinoma 
      Large cell neuroendocrine carcinoma 
      Basaloid carcinoma 
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      Lymphoepithelio like carcinoma 
      Clear cell carcinoma 
      Large cell carcinoma 
      Large cell carcinoma with rhabdoid phenotype 
5. Adeno squamous carcinoma 
6. Carcinomas with pleomorphic, sarcomatoid or sarcomatous 
elements. 
             Carcinoma with spindle and/or gaint cells. 
             Pleomorphic carcinoma 
             Spindle cell carcinoma 
             Giant cell carcinoma 
             Carcinosarcoma 
             Blastoma (pulmonary blastoma) 
             Others 
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C. CLINICIAL MANIFESTATIONS 
Bronchogenic carcinoma presents with diverse clinical 
manifestations. Clinical features may be due to the following reasons:- 
1. CLINICAL FEATURES DUE TO PRIMARY TUMOUR 
Centrally located tumours produce different symptoms than do 
peripherally located tumours. 
Clinical features due to central tumours 
Cough                              
     It is the commonest symptom and occurs in i75%  or more patients. 
Cough may be produced by a Small tumour acting as a foreign body 
interfering with bronchial peristalsis or by neoplastic erosion of bronchial 
mucosa. 
Chest pain      
 It is vague , persistent and poorly localized.It is due to  
peribronchial and perivascular nerve involvement. 
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Dysponea     
 It occurs in approximately 58%of patients. It may be due to 
Emphysema, pleural effusion,atelectasis, bronchopulmonary Infection, 
phrenic nerve paralysis and O2 transport defect  in broncho-aveolar 
carcinoma 
Hemoptysis                  
 It occurs in 5 to 51% of patients . it is usually scanty and is due to 
ulceration of bronchial mucosa                                              
Wheeze                            
 It occurs in 2% cases. It is due to fixed mechanical obstruction 
below the carina & it is not changed after cough. 
Stridor                      
 It is due to narrowing of trachea & main bronchi at  the level of 
carina. 
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Fever and sepsis  
 It is due to post obstructive pneumonia. 
2.CLINICAL FEATURES DUE TO PERIPHERAL 
TUMOURS 
Pleuritic chest Pain 
 It is either due to involvement of the parietal pleura or due  to 
pleurisy arising as a result of post obstructive segmental or sub segmental 
pneumonia. 
Dyspnoea  
 It is restrictive in nature. It is either due to pleural effusion or due 
to pleuritic chest pain. 
Cough  
 It is less common except in broncho-alveolar carcinoma. 
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Clinical features due to intrathoracic spread 
Neurological complications 
 Due to involvement of 8th cervical and 1st thoracic nerve the patient 
will present with characteristic pain in the shoulder and in the arm along 
the distribution of ulner nerve. Sensory loss with weakness and wasting 
of small muscles of the hand will occur. Patient may present with horner 
syndrome due to involvement of cervical sympathetic nerve. Involvement 
of recurrent laryngeal nerve produces hoarseness of voice & dysphagia 
(common on the left side). Diaphragmatic palsy due to phrenic nerve 
damage is a possibility. Erosion of ribs (commonly 1st and 2nd) may 
occur. 
S.V.C Obstruction                                                                             
 It is obstructed either by primary tumours or by metastatic lymph 
nodes. It was first described by William Hunter in 1757. Obstruction may 
be above or below the azygos vein. The common presenting symptoms 
are oedema of the head, neck, arms, breasts, dyspnoea, cough, and 
orthopnoea. The oedema is pitting and varies with changes in position. 
Collateral veins fill from above downwards. Its incidence ranges from 4 
to 19%. 
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Pleural and pericardial effusion 
Pleural effusion is commonly due to direct involvement of pleura 
by tumour. It may be due to lymphatic obstruction or disruption of 
thoracic duct (chylothorax). Features of cardiac tamponade, 
sinustachycardia or atrial fibrillation may appear due to involvement of 
pericardium or heart. 
Dysphagia 
It may occur due to compression of oesophagus by posterior 
mediastinal gland. Immediate cough upon swallowing may occur due to 
broncho-pleural fistula. 
Pulmonary artery constriction or pulmonary artery stenosis 
(extrinsic) may occur due to tumour involvement. 
3. CLINICAL FEATURES DUE TO EXTRATHORACIC 
METASTASIS  
 Extrathoracic metastasis is common in small cell carcinoma. It may 
involve any organ or tissue, but lymphnode, brain, liver, adrenal and skin 
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are commonly involved. Bone and brain involvement usually produce 
symptoms and others are usually silent 
Central nervous system 
Metastasis may involve the brain, meninges and spinal cord. Spinal 
cord involvement produces back pain which is localized and progressive 
in nature. Other symptoms are numbness, tingling, weakness, of an 
extremity, bladder and bowel disturbance and unsteadiness of gait. Due to 
intracranial involvement patient may present with headache, vomiting, 
altered mental status, weakness, seizures, cranial nerve abnormality, 
hemiparesis and cerebellar ataxia. 
Lymph node metastasis 
Lymphatic spread is common in small cell carcinoma, the whole of 
right lung and lower lobe of left lung ultimately drains into right 
suparclavicular gland via hilar and paratracheal nodes. Upper lobe of left 
lung drains into the para aortic, hilar and carnial nodes. Enlarged gland is 
usually painful and hard in consistency. 
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Bone metastasis 
It produces distressing and unremitting pain which may be due to 
pathological fracture or bone erosion. 
Hepatic metastasis 
Enlarged palpable liver and unusual. Hard and irregular liver 
suggests hepatic metastasis. 
Skin metastasis 
It may occur occasionally. 
4. Paraneoplastic syndrome 
    Paraneoplastic syndromes are non-metabolic or neuromascular 
complications of lung cancer. It occurs in small cell carcinoma. Ectopic 
hormones are produced from the neurosecretory granules within the 
malignant cells. 
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METABOLIC DISORDERS                                                             
Hypercalcemia 
    It is caused by ectopic parathormone secretion by tumour cells. It 
commonly occurs in squamous cell carcinoma. It is seen in about 10% of 
cancer patients. Patients present with thirst, polyuria nocturia, nausea, 
vomoiting, anorexia, abdominal pain, mental confusion, hypotonia, stupor 
and ultimately coma. 
Syndrome of inappropriate antiduresis 
It is commonest of the syndrome of tumour hormonogenesis (2-
22%) and common in small cell carcinoma. Patients present with 
headache, drowiness, mental confusion, disorientation, convulsion, coma, 
hypothermia and death. 
Clinical syndrome due to excess ACTH 
It is fairly uncommon (2%) and is widely variable in 
severity.patients present with dependent oedema, pigmentation, weakness 
and wasting muscles particularly of limb gridle. Hypertension and 
hyperglycemia may be present. Cushing’s syndrome is unusual. 
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Clinical syndrome due to other hormone 
             Oxytocin, GHRH,somotostatin, neurophysin, lipotrophin, 
prolactin, calcitonin gastrin, glucogon etc may be produced by tomour 
cells. Very rarely these hormones produce symptoms 
NEUROLOGIC AND NEUROMASCULAR DISORDER   
Peripheral neuropathy 
Commonly seen in small cell carcinoma. It may be motor, sensory 
or mixed and may be accompanied by muscle wasting or weakness. 
Autonomic neuropathy 
It may produce postural hypotension and intestinal motility. 
Cerebellar ataxia with nystagmus, impaired co-ordination and dysarthria 
may occur. 
Polymyositis/ dermatomyositis syndrome 
It is characterized by proximal muscle weakness, pain and 
tenderness and a characterized facial heliotrope rash. 
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Myasthenic syndrome 
Patients present with muscle weakness and in contrast to 
myasthenia gravis it improves with repeated effort. Other differentiating 
points are muscular wasting, loss of tendon reflex and infrequency of 
bulbar involvement.  
Hypertrophic pulmonary osteoarthropathy 
        It was first described by Bomberger (1889) and Marie (1890). 
Thompson (1904) first described its association with lung cancer. It’s 
incidence varties from 2 to 48%. Patients present with bone pain in the 
involved areas which are often hot and tender to touch. There may be 
associated pain and swelling of the wrists, ankles and knee joints. 
Clubbing occurs in 90% of cases. It is commonly associated with 
adenocarcinoma. 
Gynaecomastia 
It may occur occasionally. The histological types most frequently 
found are large cell and adenocarcinoma. Clinical features related to other 
systems are given below in the tabulated form. 
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Dermatologic 
  Pigmentation, pruritus, lanugohirsuitism ,acanthosis nigricans and 
erythema gyratum nigricans. 
8. Vascular 
Thrombophlebitis migrans, arterial thrombosis and non bacterial 
thrombotic endocarditis. 
Hematologic 
Anaemia, hemolytic anaemia, red cell aplasia, thrombocytopenic 
purpura, intravascular coagulation, hypofibrinogenemia and eosinophilia. 
Immunologic  
Dermatomyositis, systemic sclerosis, membranous glomerulo 
nephritis & rickets. 
General systemic 
Pyrexia, anorexia, cachexia and taste dysfunction. 
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D.INVESTIGATIONS 
1. Conventional chest radiography 
Radiological manifestation differs in centrally located and 
peripherally located tumours. Slight prominence of hilar shadow is the 
early radiologic finding of centrally located tumours. Peripherally located 
tumours initially present as a small nodule. Squamous cell carcinoma is 
centrally located in 65%of cases. It may persent as ill defined hilar mass 
which represents a summation of primary mass, consolidated lung & 
metastatic adenopathy. Due to partial or complete obstruction of bronchus 
it may present as post obstructive preumonitis or collapse. Collapse may 
be segmental, lobar or whole lung. Diaphragm is elevated if phrenic 
nerve is involved. Peripheral nodules are often very large, the borders of 
the nodule are often poorly defined or lobulated. The mass of squamous 
cell carcinoma frequently cavitates due to cetral necrosis. The cavities are 
typically thick walled with an ir regular inner surface, squamous cell 
carcinoma is the frequent cause of pancoast tumour. Adenocarcinomas 
present as peripheral mass in 60 to 70% cases. The peripheral nodules is 
usually round or oval in shape. They are ill defined or lobulated or 
sunburst appearance. It may present as a slow growing  or fairly stable 
peripheral nodules. Adenocarcinoma may present as central; mass. 
 23
Broncho-alveolar carcinoma most commonly present as a very slowly 
growing circumscribed localized nodule. One unique feature of this 
nodule is the presence of air bronchogram. The diffuse forms of alveolar 
cell carcinoma includes an ill defined mass, coalescent multinodular 
infilterate and lobar consolidation. Other radiographic manifestation are 
pleural effusion   (8- 10%)  atelectasis, pneumothorax or cavitation. 
Large cell carcinoma presents like adenocarcinoma. It is frequently 
larger than 4 cms in diameter. Poorly defined or lobulated margin is 
common. Small cell carcinoma is usually small and it is difficult to detect 
on a radiograph. Radiologically most typically it is manifested as a 
central mass due to involvement of ipsilateral hilar or madiastinal 
lymphnodes. It is the least common cause of peripheral mass 
Unusual radiographic manifestations 
a) Spontaneous regression or decrease in size 
b) Calcification 
c) Thin walled cavity 
d) Meniscus or air crescent sign 
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e) Alveolar pattern  
f) Satellite nodules 
g) Double lesion sign 
h) Mucoid impaction 
i) Obstructive hyperinflation 
j) Spontaneous pneumothorax 
k) Diffusion nodular pleural tumour spread  
l) Loculated pleural effusion 
2. Sputum cytology 
Examination of 5 separate sputum sample using the papanicolaou 
staning of fixed sputum smear can detect 70-80% of all primary tumours. 
The yield is better for centrally located tumours (80%) than for 
peripherally located tumours (42%). The more productive times to collect 
specimens are in the immediate post bronchoscopy period or when the 
patient is raising blood streaked sputum. The following are the factors 
influencing the ratr of detection of malignant cells in sputum. 
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a)   Large tumour size 
b)   central tumour location 
c)   Exfoliating carcinoma 
d)   lack of tumour differentiation 
e)   Histological type 
f)   Lobe of the lung involved.  
The first sputum of the morning is usually product of deep cough 
and tends to produce a higher positive yield. Induced sputum is more 
representative. Sputum may be collected by transtracheal aspiration, 
tracheobronchial aspiration or bronchoscopic aspiration. Early diagnosis 
is possible by cytology but prognosis does not change.  
3. Fine needle aspiration cytology (percutaeneous) 
The cytodiagnosis of lung nodules has improved during the  last 
decade due to improved localization technique (CT scan and ultrasound). 
Lesions less than 1 cm in diameter can be successfully aspirated using 21 
to 23 gauge needles. The presence of new or peripheral localized lung 
lesion less than 2 cm in diameter, located in the outer 1/3rd of the lung and 
not visualized through bronchoscope constitutes an indication for FNAC. 
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4. Bronchoscopy 
Killian first introduced rigid bronchoscope in 1897. Ikeda’s 
introduction of the flexible fibreoptic bronchoscope in 1966 has  made a 
great impact on the practice of respiratory medicine. A major advance has 
been achieved in visualizing, and sampling, bronchial pathology very 
much more peripherally than rigid bronchoscope. It can be introduced 
with local asaesthesia and complication is remarkably low. Among 
patients with central or hilar masses, bronchoscopy is diagnostic in 68 to 
98% cases. For peripheral nodular or masses it is diagnostic in 
approximately 50%cases. Abnormalities in the lung apices and superior 
basal segments of lower lobes may be difficult to approach by fibreoptic 
bronchoscope. Bronchoscopically, tumours, or metastatic hymph node 
enlargements may produce visible changes of three main types: 
1. Simple distortion of the normal anatomy by external 
pressure on bronchial tree 
2. involvement of the bronchial wall with local distortion or 
ulceration of the mucosa and 
3. intraluminal eruption of the growth. 
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Obtaining specimens from the bronchial tree during endoscopy is a 
vital part of diagnosis of bronchogenic carcinoma. Material may be 
produced by the following methods: 
a. Aspiration of bronchial secretion 
With a specimen trap in circuit, gross specimen of secretion can be 
obtained directly via the aspirating channel of the fiberscope. Maximum 
yield is obtained by drawing a little normal saline through the instrument 
at the end of the operation. Diagnostic yield is high when the mass is 
endobronchial and centrally located, particularly situated in lower lobes. 
b. Bronchial brushing 
Brusing taken from the surface of area suggesting tumour tissue 
frequently give positive diagnoses. The method is particularly useful in 
small bronchi, where the forceps will not open or when used blindly 
where a tumour beyond vision is suspected. 
c. Endobronchial biopsy 
The most critical bronchoscopic manoeuvre is taking the biopsy. 
The specimen obtained is very small but usually adequate because it’s 
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source can be clearly chosen. All specimens are placed in 10% formol-
saline for transport to the laboratory. Haemorrhage has to be avoided. 
d. Transbronchial needle aspiration 
Sometimes the best chancve of reaching a diagnosis 
bronchoscopically, when no intraluminal lesion is found, is to obtain 
biopsies from enlarged lymph nodes that are obviously distorting bronchi. 
Transbronchial needle aspiration is the safest technique here. Strong 
aspiration through a wide bore needle will remove tissue for cytological 
examination. 
e. Transbronchial lung biopsy 
It provides one of the safest ways of obtaining small biopsies of the 
lung parenchyma particularly when the disease is diffuse. 
f. Biopsy of peripheral lesions 
The procedure is undertaken in radiographic department under 
fluoroscopic guidance. Radiologically controlled, percutaneous needle 
biopsy of small peripheral lesions is quicker and more accurate. 
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5. Computed tomography and MRI 
In patients with tumour of bronchial orgin, CT scanning provides 
detailed information critical to accurate tumour staging. CT scanning has 
provided especially valuable as a complementary procedure to fibreoptic 
bronchoscopy. As compared with CT, at present the role of MR imaging 
is less well defined. Preliminary data suggest that in the diagnosis of 
mediastinal adenopathy it provides similar results to those obtained with 
CT. 
6.  Investigations for secondary metastasis 
For lumph node metatasis fine needle aspiration cytology and 
biopsy of the suspected node mey be done. To exclude hepatic metastasis 
liver function tests,isotope scan, ultrasound investigation frequently 
misses metastssis. Biopsy under direct vision is the best for positive 
histology. 
For suspected brain metatasis the confirmatory investigation of 
choice is computed tomography with contract enhancement. Cytological 
examination of C.S.F may be done in suspected case of meningeal 
involvement. 
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Barium swollen x-ray or CT scan is done to exclude esophageal 
compression by metastasis lymphnodes. Fluoroscopy may be done to 
exclude diaphragmatic palsy. For suspected bone involvement ,elevated 
levels of alkaline phosphatase and gamma gultamyl tranferase may be 
helpful. Bone scanning is much more sensitive than conventional x-ray 
and false negative result is less than 2%. 
Cytological examination of pleural fluid for malignant cells may be 
helpful for diagnosis. 
7. Bio-chemical and hormonal changes 
In tumour associated ACTH secretion, the measurement of ACTH 
and its associated peptides in blood is of limited value because of 
significant false positive and false negative results. Usually plasma 
cortisol conc.exceeds 30 g/dl and plasma corticotrophin is persistently 
high, above 200 g/ml. urinary excretion of unbound cortisol and cortisol 
metabolites is abnormally high. Plasma k+ is less than 3.3 meq/L with 
high plasma bicarbonate and alkaline pH. Glucose intolerance is 
sometimes present.    
Periodic assessment of serum calcium is obligatory in the 
management of lung cancer. Bronchogenic carcinoma associated 
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parathormone is not similar to conventional parathormone. So 
parathromone estimation is of limited value. These patients may differ 
from those of primary hyperparathyroidism in tht they intend to be more 
severely hypercalcemic (serum conc > 14mg/dl) 
Cancer should always be included in the different diagnosis of 
patients who present with hyponatremia. It is due to inappropriate 
secretion of ADH by tumour cells. ADH measurement by radio- 
immunoassay has demonstrated that more than 30% of small cell 
carcinoma patients has a high concentration ofADH in blood. Sodium 
concentration becomes low. Plasma osmolality becomes less than        
260 mosmo/kg H2O (normal 285-295 mosmo/KgH2O) and urine 
osmolality rises (usually 400-500 mosmo/KgH2O). 
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MATERIALS AND METHODS 
An open prospective study of patients who attended THORACIC 
Medicine Department at Government General Hospital Chennai, and 
Institute of Throracic Medicine, Chetpet, with clinical and/or radiological 
suspicion of lung cancer was studied over a period of 12 months between 
January 2005 and 2006. The study protocol included a detailed history 
regarding the onset and progress of the disease, smoking habits and other 
associated risk factors if any. 
Inclusion criteria 
All the patients who had clinical features and radiological 
abnormalities suggestive of lung cancer have been included. 
Exclusion criteria: 
Among the patients included in this study those did not have 
histopathological proof have been excluded and the remaining were 
analysed.  
The complaints which were evaluated in detail included cough, 
sputum, chest pain, dyspnea, fever, weight loss, hoarseness of voice, 
dysphagia and symptoms suggestive of SVC obsturuction, paraneoplastic 
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syndromes and systematic metastasis. A detailed general and systematic 
examination was preformed. All patients were subjected to baseline blood 
investigations, chest x ray PA and lateral view, ultrasound abdomen and 
chest. Computerized Tomography of chest was done to characterize the 
lesion further and t help to arrive at tissue diagnosis. FOB was done in 
some patients to detect and aid in getting at histopathological diagnosis. 
Following investigations helped in the histopathological 
confirmation of the diagnosis. 
1. Computerized Tomography guided needle biopsy 
2. Ultrasound guided needle biopsy 
3. Endobronchial biopsy with Fiberoptic bronchoscopy 
4. Excision biopsy of supraclavicular node 
5. Pleural fluid cytology. 
Fiberoptic bronchoscope was performed with a single channel  
(pentax, Japan).Bronchoscope (pentax,Japan). Under local anesthesia, 
2ml of 2% Lignocaine was injected transtracheally after test dose along 
with spraying of 4% lignocaine using hand atomizer just prior to the 
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procedure. Lignocaine jelly was applied to the effective length of 
Fiberoptic bronchoscope. The Fiberoptic bronchoscope was passed 
transnasally in the supine position. The normal side was visualized first 
and then the suspected abnormal side. Biopsy was performed in patients 
with obvious endobronchial lesion. Mucosal brushings were-obtained 
from the area surrounding the abnormal segment on radiological basis in 
case of patients without endobronchial lesion. A central tumour was 
defined as a tumour that was evident within the ebronchial tree at 
Fiberoptic bronchoscopy  and a peripheral tumor as one that was not 
visualized at bronchoscopy. Xray wise central tumor was defined as 
tumors arising beyond the hilum. A post bronchoscopic sputum was sent. 
Patients were subjected to percutaneous lymphnode aspiration and 
cytology. 
Computerized Tomography/Ultrasound guided needle biopsy was 
done in patients when indicated. The biopsy was done using Atovac gun, 
core biopsy needle. The needle size was 8G, 10cm to 15cm in length with 
1cm markings. The distal tip was ultrasound sensitive, the needle also has 
an over sheath cannula for computerized Tomography guidance. The 
needle length was adjusted using pins. With computerized 
Tomography/Ultrasound guidance the lesion was localized, under cover 
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of local anesthesia the needle length was adjusted according to the lesion 
and core biopsy obtained which was 2cm to 3cm bit. In indicated patients 
pleural fluid aspiration cytology was done under aseptic precaution with 
adequate local anesthesia.  
The specimens obtained were: 
Computerized Tomography guided needle biopsy 
   Fiberoptic bronchoscope brushing and biopsy  
 Ultra sound guided- Needle biopsy. 
Smears for cytology were fixed in isopropyl alcohol for 30mts and 
stained with Hematoxylin and eosin stain. Smear was air dried and fixed 
in methanol for 30 minutes. All dried smears were fixed with MGG (may 
grunwald Giemsa) stain, slides were mounted and reported under 
microscope by cytopathologist. 
Biopsy specimens were fixed in formaldehyde (10%) for 24 hrs 
and auto processed. These slides were stained with hematoxylin and eosin 
and reported by pathologist. Special stains were used as required. Pleural 
fluid was centrifuged and smears stained in Hematoxylin and eosin.   
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RESULTS 
123 Patients were included in the study. Pathological diagnosis was 
possible in patients. Eleven patients in whom cell type diagnosis was not 
possible the procedure done for pathological diagnosis were inconclusive. 
The eleven patients had x-ray features suggestive of mass lesion along 
with computerized tomography of the chest confirming the same. In these 
eleven patients malignant cells could be identified but the exact cell type 
diagnosis was not possible. 
Age:   In our study the age ranges from 28-82 years. 
AGE INCIDENCE IN THIS STUDY 
Age in years No. of patients Percentage 
<39 6 4.87 
40-49 22 17.88 
50-59 33 26.82 
60-69 45 36.58 
>70 17 13.82 
Total 123 100.00 
 
Sex:  No. of Males       : 107 
No. of Female     : 16 
Male, Female ratio was 6.6:1 
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SEX INCIDENCE OF LUNG CANCER IN RELATION  
TO CELL TYPES IN THIS STUDY 
Female Male 
Type 
No % No % 
Squamous cell 
carcinoma 
 
Adenocarcinoma 
 
Small cell 
carcinoma 
 
Large cell 
carcinoma 
 
Mucoepidermoid 
carcinoma 
2 
 
 
12 
 
 
nil 
 
nil 
 
 
nil 
1.78 
 
 
10.71 
 
 
nil 
 
nil 
 
 
nil 
62 
 
 
29 
 
 
4 
 
2 
 
 
1 
55.35 
 
 
25.89 
 
 
3.57 
 
1.78 
 
 
0.892 
Total 14 12.49 98 87.51 
 
Clinical features 
The pulmonary symptoms most commonly presented were cough 
was present in103 patients (83.79%) followed by chest pain in 65 patients 
(52.84%) and dyspnea  in 71 patients (57.72%), hemoptysis in 39 patients 
(31.70%), 24 patients (19.51%) of the 123 patients included in this study 
gave history suggestive of treatment for tuberculosis in the past and most 
common cell type associated was adenocarcinoma. 
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HISTOLOGICAL TYPES AND SYMPTOMATOLOGY 
Cell type 
Squamous 
carcinoma 
Adeno 
carcinoma 
Small cell 
carcinoma 
Large cell 
Carcinoma 
Mucoepidermoid 
Carcinoma 
Symptom 
no % no % No % no % No % 
Total 
Cough 63 61.63 30 29.12 3 2.91 2 1.94 1 0.97 103 
Dyspnea 55 77.46 14 19.71 1 1.4 1.4 1.4 Nil nil 71 
Chest pain 49 75.38 12 18.46 3 4.61 1 1.53 Nil nil 65 
Hemoptysis 30 76.92 5 12.82 3 5.08 1 2.56 nil Nil 39 
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Smoking 
97 patients were smokers, 26 patients were non smokers. None of 
the females in this study were smokers. 
SMOKING INDEX AND NUMBER OF PATIENTS 
Smoking index Patients Percentage 
0 
 
<100 
 
100-300 
 
>300 
26 
 
2 
 
16 
 
79 
21.38 
 
1.62 
 
13.00 
 
64.22 
Total 123 100.00 
 
The most common cell types among smokers were squamous cell 
carcinoma. 26 patients were non smokers. Among non smoking patients 
the most common pathological diagnosis was adeno carcinoma14 
(53.84%), followed by squamous cell carcinoma 9 patients (34.61%). 
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HISTOPATHOLOGICAL TYPES RELATED TO SMOKING 
Squamous 
cell 
carcinoma 
Adeno 
carcinoma 
Small cell 
carcinoma
Large cell 
carcinoma
Muco 
epidermoid Feature 
No % No % No % No % No % 
Total 
Smoking 55 63.95 24 27.9 4 4.65 2 2.32 1 1.62 86* 
 
* Typed patients only included 
Passive smoking 
2 female patients gave definite history suggestive of passive 
smoking. One male had the history of passive smoking.2 had 
adenocarcinoma and patients had squamous cell carcinoma. 
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Clubbing  
41 (33.33%) patients presented with clubbing. All patients with 
small cell carcinoma had no clubbing. 
TYPES OF LUNG CANER AND CLUBBING 
 
Type Patients % 
Squamous cell Carcinoma 27 65.85 
Adeno carcinoma 12 29.26 
Small cell carcinoma Nil Nil 
Large cell carcinoma 1 2.4 
Mucoepidermoid 1 2.4 
Total 41 100 
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Chest X-ray features 
The most common presentation was mass lesion 
RADIALOGICAL FEATURES OF DIFFERENT CELL TYPES 
Squamous 
Cell 
Adeno 
carcinoma 
Small cell 
carcinoma 
Large cell 
carcinoma 
Muco 
epidermoid Type of 
Lesion 
No % No % No % No % No % 
Total 
Right side 34 50.74 27 40.29 3 4.47 2 2.98 1 1.49 67 
Left side 30 63.82 16 34.04 1 2.12 Nil Nil Nil Nil 47 
Hilar mass 10 47.61 8 38.09 2 9.52 Nil Nil 1 4.76 21 
Pulmonary 
mass 
45 71.42 15 23.8 1 1.58 2 3.17 Nil Nil 63 
Cavitary 
mass 
2 100 Nil Nil Nil Nil Nil Nil Nil Nil 2 
Mediastinal 
Widening 
6 85.71 Nil Nil L1 14.28 Nil Nil Nil Nil 7 
Consolidation 3 60 2 40 Nil Nil Nil Nil Nil Nil 5 
Collapse 10 100   Nil Nil Nil Nil Nil Nil 10 
Coin lesion   3 100 Nil Nil Nil Nil Nil Nil 3 
Rib erosion 6 100   Nil Nil Nil Nil Nil Nil 6 
Pleural 
Effusion 
16 47.05 18 52.95 Nil Nil Nil Nil Nil Nil 34 
Pericardial 
effusion 
2 100 Nil Nil Nil Nil Nil Nil Nil Nil 2 
Diaphragm 
elevation 
2 100 Nil Nil Nil Nil Nil Nil Nil Nil 2 
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Sputum cytology was positive in 6 patients (4.87%) and most 
common tumor associated was squamous cell carcinoma. Post 
bronchoscopic  sputum cytology was positive in 8 patients (6.5%) and 
most common cell associated was squamous cell carcinoma. 
               SVC obstruction was seen in 8 patients (6.50%) and most 
common cell type was squamous cell carcinoma 5 patients (62.5%), small 
cell 2 patients ( 25 %), CNS metastasis was seen in 9 patients (7.31%) 
and most common cell type was adenocarcinoma 6 patients (71.428%), 
liver metastasis was present in 2 patients (1.62%) and most common cell 
type was squamous cell carcinoma. Hoarseness of voice was present in 9 
patients (7.31%) and actual vocal cord palpsy was present in 7 patients. 
Computerized Tomography scan was done in 98 patients. 
Computerized Tomography helped in histopathological diagnosis by way 
of computerized Tomography guided needle biopsy of suspected mass in 
60 patients, positive results was obtained in 45 (75%). The pathological 
diagnosis could not be got through computerized Tomography guided 
biopsy in 15 patients. Positive brochus sign was present with rib/ 
vertebral metastasis, 9 patients with mediastinal modes, 2 patients with 
nodules in the lung, 2 patients with rib erosion, 1 patient with military 
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carcinomatosis, 1 patient with malignant effusion and pleural nodules, all 
which were not seen on chest x-ray. 
Fiberoptic bronchoscope was done in 56 patients. 80%had cenetral 
tumors. Bronchial cytology yielded positive results in 31 (55.39%). 
Endobronchial biopsy yielded positive results in 11 (73.33%) of the 15 
performed patients. 
Supracalvicular node biopsy yielded positive results in 12 
patients.pleural fluid cytology was positive for malignant cells in 14 
patients. 
The interventional procedures had very minimal complications 
with no mortality. 3 patients developed pneumothorax during 
computerized Tomography guided biopsy, of which only 1 patient needed 
intercostals drainage, the rest settled with symptomatic treatment, 2 
patients had minimal hemoptysis. During fiberoptic bronchoscope 5 
patients had hemoptysis which was mild to moderate. 
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MODALITIES USED TO PROVE CARCINOMA 
 
Modality Number percentage 
Fiberoptic bronchoscope 42 34.14 
Ultrasonogram 29 23.57 
Computerised tomogram 26 21.13 
Node biopsy 12 9.75 
Pleural fluid cytology 14 11.38 
Total 123 100.00 
 
 
SPECIFIC HISTOLOGICAL TYPES IN THIS STUDY 
Histological types No. of patients Percentage 
Sqamous cell carcinoma 64 52.03 
Adeno carcinoma 41 33.33 
Small cell carcinoma 4 3.25 
Large cell carcinoma 2 1.62 
Mucoepidermoid 1 0.81 
Not typed 11 8.94 
Total 123 100.00 
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SPECIFIC HISTOLOGICAL TYPES IN THIS STUDY 
 
 
Histological types
52%
33%
3% 2%1%
9%
Sqamous cell carcinoma Adeno carcinoma
Small cell carcinoma Large cell carcinoma
Mucoepidermoid Not typed
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COMPARITION OF CELL TYPES PAST AND PRESENT 
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DISCUSSION 
Lung cancer is becoming the most common cause of cancer death 
for both men and women and it is a growing world wide problem, 
especially, in developing countries like India. In the recent past there has 
been many advances in the early detection, staging, prevention and 
treatment of lung cancer. The histopathologic appearance of lung 
carcinoma remains an important guide to prognosis and treatment. 
In this prospective study of 123 patients, 123 patients had 
confirmed pathological diagnosis but 11 patients had evidence of 
malignant cell but repeated sampling did not yield the cell type. 
The mean age range was from 28 to 82 years. The maximum 
number of patients in this study was between 50-69 years. This is in 
corroboration with the studies conducted in India and abroad. 
107 patients were males and 16 patients were females. The male: 
female ratio was 6.6:1. In a study conducted in Mumbai in 1999 the ratio 
was 4.2:1. The picture is not the same in certain countries and in Japan 
the studies have shown 3:8:1 ratio and raising numbers in female. 
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The most common Histopathological type among males was 
squamous cell carcinoma and the most common type among female was 
adenocarcinoma. This is in corroboration with other studies conducted in 
India. 
The most common pulmonary symptom in this study was cough 
103 patients followed by dyspnea 71 patients and chest pain 65 patients 
and hemoptysis 39 patients. The pulmonary symptoms were more 
common with squamous cell carcinoma. This is consistent with the study 
conducted in India in 1999 by PN Chhajed et al., at Mumbai. 
24 patients of 123 patients gave history suggestive of tuberculosis 
and treatment for the same. The most common cell type among these 
patients was adeno carcinoma. This is in corroboration with the study 
conducted in India and abroad. 
Smoking had been established beyond doubt as one of the definite 
risk factors foe Bronchogenic carcinoma. In this study 97 patients were 
smokers, 26 patients were non smokers. None of the female in this study 
was smokers. The most common cell type among smokers was squamous 
cell carcinoma followed by Adenocarcinoma. All 4 patients who had 
small cell carcinoma were smokers. All the patients who had large cell 
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and anaplastic carcinoma were smokers. Smoking index >300 showed a 
significant increase in the incidence of squamous cell carcinoma over 
other cell types. This is consistent with the studies conducted by PN 
Chhajed et al at Mumbai in 1999 and also in studies conducted by 
Samet JM and published in chest 1993. 
Among non smokers the most common pathological diagnosis was 
Adenocarcinoma. This is in corroboration with studies conducted in India 
by Arora VK et al in 1990 and in the west by Budix E.al in oct 
1999. 
Clubbing was seen in 41 patients (33.33%) in this study and the 
most common cell type associate was squamous cell carcinoma. This is 
inn corroboration with the studies conducted by Baughman RPet.al 
in 1998 published in journal of clinical and experimental Rheumatology. 
Chest x-ray analysis revealed that the commonest presentation was 
mass lesion which was seen in 84 patients (75%). This is in corroboration 
with the studies conducted in India and in the west. 
Sputum cytology was positive in only 6 patients (4.87%) and the 
most common tumour associated was squamous cell carcinoma. Post 
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bronchoscopic   cytology wasd positive in 8 patients (6.5%) cytological 
techniques have not improved or modified in the recent years probably 
that is why positive yield was low. Biopsy have been improved by 
immunohistochemistry and mucin staining probably that is why yield is 
more.  
Computerized tomography study was done in 98 patients. 
Computerized tomography guided needle biopsy of suspected mass lesion 
was done in  60 patients,positive results were obtained in 45(75%) 
patients.this is slightly less in shanker-s  et al at PGIMER(july 1998) 
Fiberoptic bronchope was done in 56 cases fiberoptic bronchopy 
helped in 11 patients by way of endobronchial biopsy. The positive yield 
was 73.33%.this is high compared to study conducted by Vattana Thum 
A et al at Bangkok  in Thailand whose yield was only 50% with out 
transbronchial needle aspiration(August 1999) 
34 patients under went for USG guided biopsy and 29 patients 
were diagnosed this is close to the results done by Knudsen DV  
et al. at Denmark(1996 may).in 3 patients it was done twiceto get a 
definite cell type. 
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Histopathological analysis revealed that the commonest cell type in 
this study was squamous cell carcinoma 64(52.03%) patients , followed 
by adenocarcinoma followed by41(33.33%),  4(3.25%) patients had small 
cell carcinoma.2(1.62%) patients had large cell carcinoma.  
1 (.88%) had mucoepidermoid carcinoma.Squamous cell carcinoma still 
remained the leading cause of lung cancer in this study. Adenocarcinoma 
remains the second most common histological subtype of lung cancer in 
this study.A study conducted at Hyderabad by Thippanna et al, showed 
that the predominant cell type was squamous cell carcinoma.                                            
A study conducted in Mumbai by P.N.Chajed et al., showed adeno 
carcinoma was the predominant cell type which did not correlate with this 
studying the studies in United states by Samet J M., and Beckett W S., on 
epidemiology of lung cancer had shown adeno carcinoma  to be the 
commest.The reasons cited by them mainly were raise in female smokers 
and change in smoking pattern.  
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CONCLUSIONS 
1. The most common pathological cell type in this study was squamous 
cell carcinoma followed by adenocarcinoma. 
2. Male sex, age >50 years, history of tobacco smoking were still a risk 
factor for Lung cancer. 
3. Male, female ratio 6.6:1 
4. Adenocarcinoma was found to be the commonest cell type of cancer 
among females and non smokers. 
5. Clubbing was most commonly associated with squamous cell 
carcinoma. 
6. most common radiological presentation was mass lesion. 
7. Fiberoptic bronchoscope biopsy and brushing, computerized 
tomography/ ultra sonogram core needle biopsy were valuable tools to 
get at tissue diagnosis in 80% of patients. 
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